A5021164683- Lung Cancer Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Radiation Therapy and Dosimetry
- Management of metastatic bone disease
- Head and Neck Cancer Studies
- Radiomics and Machine Learning in Medical Imaging
- Lung Cancer Treatments and Mutations
- Occupational and environmental lung diseases
- Lung Cancer Research Studies
- Pleural and Pulmonary Diseases
- Sarcoma Diagnosis and Treatment
- Industrial Vision Systems and Defect Detection
- Photodynamic Therapy Research Studies
- Ultrasound and Hyperthermia Applications
- Effects of Radiation Exposure
- Medical Imaging and Analysis
- Medical Imaging and Pathology Studies
- Brain Metastases and Treatment
- Gastric Cancer Management and Outcomes
- Boron Compounds in Chemistry
- Cancer, Stress, Anesthesia, and Immune Response
- Artificial Intelligence in Healthcare and Education
- Machine Learning in Healthcare
- Beetle Biology and Toxicology Studies
- Cardiac tumors and thrombi
New York Proton Center
2019-2024
Memorial Sloan Kettering Cancer Center
2021-2022
Polytechnic University of Turin
2021
University of Maryland, Baltimore
2017-2018
University of Maryland Medical Center
2017-2018
University of Pennsylvania
2013-2016
Hospital of the University of Pennsylvania
2012
National Cancer Institute
2009-2011
Abstract Background FLASH therapy is a treatment technique in which radiation delivered at ultra-high dose rates ( ≥ 40 Gy/s). The first-in-human FAST-01 clinical trial demonstrated the feasibility of proton extremity bone metastases. objectives this investigation are to assess toxicities and pain relief study participants with painful thoracic metastases treated radiotherapy, as well workflow metrics setting. Methods This single-arm being conducted under an FDA investigational device...
Abstract Background: “In situ vaccination” immune-gene therapy has the ability to induce broad, polyclonal anti-tumor responses directed by patient's own immune system using standard “off shelf” agents. In this trial, we activated endogenous tumor immunity injection of an adenovirus expressing a Type I interferon into pleural space patients with malignant mesothelioma (MM). Based on preclinical data showing synergy chemotherapy, all then received systemic cytotoxic therapy. Methods: Two...
Purpose: In the light of tumor regression and normal tissue changes, dose distributions can deviate undesirably from what was planned. As a consequence, replanning is sometimes necessary during treatment to ensure continued coverage or avoid overdosing organs at risk (OARs). Proton plans are generally thought be less robust than photon because proton beam's higher sensitivity changes in composition, suggesting also likely rate due regression. The purpose this study compare dosimetric...